Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

About FDA

DDMAC - Enforcement Actions - August 25, 2011

The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in our second Enforcement Webinar, which was held on August 25, 2011. This is a pilot program in which DDMAC will give our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by DDMAC in a given quarter. This particular webinar covered Warning Letters and Untitled Letters issued from May 2011 to August 2011.

These focused Webinars will support DDMAC's mission to protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.
 
View presentation slides here: Enforcement Webinar 8/25/11 (PDF - 655KB)

Page Last Updated: 05/03/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English